Drs. Brad Schwartz, CEO of the Morgridge Institute for Research; Terri Young, Chair of the Department of Ophthalmology and Visual Sciences (DOVS); and David Gamm, Director of the McPherson Eye Research Institute (MERI); are pleased to announce the recipient of the $25,000 grant award for Metabolism Research in Age-Related Macular Degeneration. This pilot award is funded by the Morgridge Institute and the James Christenson Estate Macular Degeneration Research Fund.
Author: Brian Mattmiller
UW spinoff SHINE Medical hits major funding milestone
SHINE Medical Technologies, a medical isotope company developing technology that originated from University of Wisconsin–Madison research, has signed a $125 million term sheet that represents a massive step in bringing an important medical advance to market.
Bill Swisher joins Morgridge as Chief Development Officer
Bill Swisher, the assistant vice president for corporate and institutional partnerships at Carnegie Mellon University (CMU), has been named the new chief development officer of the Morgridge Institute for Research.
‘Tissue chip’ offers better approach to screen neural toxins
A multidisciplinary team at the University of Wisconsin–Madison and the Morgridge Institute for Research is creating a faster, more affordable way to screen for neural toxins, helping flag chemicals that may harm human development.
Andreas Velten: Taking imaging to new extremes
Unlike many of us, Andreas Velten loves working in windowless rooms. His research tools are shrouded in sealed black boxes to keep out unwanted light. He’s been known to cover red building exit signs to extinguish any trace of visual noise.